Insider Transactions in Q2 2022 at Epizyme, Inc. (EPZM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,156
+6.71%
|
$16,156
$1.47 P/Share
|
|
Jun 30
2022
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,204
+14.07%
|
$10,204
$1.47 P/Share
|
|
Jun 30
2022
|
Beveridge, Roy A Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,928
+16.24%
|
$8,928
$1.47 P/Share
|
|
May 17
2022
|
Beveridge, Roy A Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+19.51%
|
-
|
|
May 17
2022
|
Carl Goldfischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+28.97%
|
-
|
|
May 17
2022
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+14.72%
|
-
|
|
May 17
2022
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+4.14%
|
-
|
|
May 17
2022
|
Michael F Giordano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+34.53%
|
-
|
|
May 17
2022
|
Carol Stuckley Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+25.93%
|
-
|
|
May 17
2022
|
Victoria Richon Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+28.46%
|
-
|
|
May 17
2022
|
Kenneth Bate Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,994
+34.53%
|
-
|
|
Apr 11
2022
|
Jeffery Kutok Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,741
-2.82%
|
$0
$0.9 P/Share
|